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Abstract 30 
 The SALMFamides are a family of neuropeptides that occur in species belonging to the 31 
phylum Echinodermata. The prototypes for this neuropeptide family (S1 and S2) were discovered in 32 
starfish but subsequently SALMFamides were identified in other echinoderms. There are two types 33 
of SALMFamides: L-type, which have the C-terminal motif SxLxFamide, and F-type, which have 34 
the C-terminal motif SxFxFamide. They are derived from two types of precursor proteins: an L-type 35 
SALMFamide precursor, which comprises only L-type or L-type-like SALMFamides and an F-type 36 
SALMFamide precursor, which contains several F-type or F-type-like SALMFamides and, 37 
typically, one or more L-type SALMFamides. Thus, SALMFamides occur as heterogeneous 38 
mixtures of neuropeptides - a SALMFamide salmagundi. SALMFamides are produced by distinct 39 
populations of neurons in echinoderm larval and adult nervous systems and are present in the 40 
innervation of neuromuscular organs. Both L-type and F-type SALMFamides cause muscle 41 
relaxation in echinoderms and, for example, in starfish this effect of SALMFamides may mediate 42 
neural control of cardiac stomach eversion in species that feed extra-orally (e.g. Asterias rubens). 43 
The SALMFamide S1 also causes inhibition of neural release of a relaxin-like gonadotropin in the 44 
starfish Asterina pectinifera. An important issue that remains to be resolved are the relationships of 45 
SALMFamides with neuropeptides that have been identified in other phyla. However, it has been 46 
noted that the C-terminal SxLxFamide motif of L-type SALMFamides is a feature of some 47 
members of a bilaterian neuropeptide family that includes gonadotropin-inhibitory hormone (GnIH) 48 
in vertebrates and SIFamide-type neuropeptides in protostomes. Similarly, the C-terminal 49 
FxFamide motif of F-type SALMFamides is a feature of vertebrate QRFP (26RFa)-type 50 
neuropeptides. These sequence similarities may provide a basis for molecular identification of 51 
receptors that mediate effects of SALMFamides. Furthermore, analysis of the actions of the 52 
heterogeneous mixtures of SALMFamides that occur in echinoderms may provide new insights into 53 
the physiological significance of the general phenomenon of precursor proteins that give rise to 54 
neuropeptide “cocktails”.  55 
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1. Introduction 59 
 Twenty-five years ago a paper reporting “FMRFamide-like immunoreactivity in the nervous 60 
system of the starfish Asterias rubens” was published in Biological Bulletin [27]. When the paper 61 
was submitted for peer review, the feedback from reviewers was supportive but the tone leaned 62 
towards “yet another paper reporting FMRFamide-like immunoreactivity in an invertebrate!” This 63 
was not unreasonable because by 1989, twelve years after FMRFamide was identified as a 64 
cardioexcitatory neuropeptide in molluscs [61], there was already a long list of species and phyla in 65 
which the presence of FMRFamide-like immunoreactivity had been reported [60]. In fact, a paper 66 
reporting the absence of FMRFamide-like immunoreativity in starfish would have been more 67 
surprising! What made the paper of interest was that it was the first to reveal the anatomical 68 
distribution of any neuropeptide(s) in the nervous system of an echinoderm. Furthermore, it laid the 69 
foundations for discovery of the first neuropeptides to be identified in echinoderms, SALMFamide 70 
neuropeptides, which are the focus of this review article. 71 
 The review is divided into five main sections corresponding to the five classes of extant 72 
echinoderms. The Asteroidea (starfish) lead the review because it was in species belonging to this 73 
class (Asterias rubens and Asterias forbesi) that SALMFamide neuropeptides (S1 and S2) were first 74 
identified [30]. The Holothuroidea follow because soon after the discovery of S1 and S2, two 75 
SALMFamide neuropeptides were identified in the sea cucumber Holothuria glaberrima [20], 76 
providing the first evidence that SALMFamides may occur throughout the phylum Echinodermata. 77 
Then come the Echinoidea, which through analysis of genome/transcriptome data from the sea 78 
urchin Strongylocentrotus purpuratus provided the first insights into the diversity of 79 
SALMFamides that occur in an echinoderm species [32, 64]. Lastly the Ophiuroidea and Crinoidea, 80 
the two echinoderm classes for which least is currently known but which have the potential to 81 
provide fascinating insights into the evolution and physiological roles of SALMFamide 82 
neuropeptides. 83 
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 Before proceeding, perhaps an explanation for the title of this review is necessary. The word 84 
salmagundi is thought to originate from the French word salmigondis, which translates as “an 85 
assortment” or “a collection containing a variety of things”. In English the word salmagundi has 86 
become associated with a 17th century salad dish comprising a rich variety of ingredients including 87 
meats, seafood, nuts, fruit, vegetables etc. However, like its French counterpart, salmagundi also 88 
has the more general meaning of a “heterogeneous mixture”. As described in more detail below, 89 
genome sequence data and/or transcriptome sequence data have revealed that there are indeed 90 
heterogeneous mixtures of SALMFamide neuropeptides in echinoderms. Thus, there are both L-91 
type SALMFamides and F-type SALMFamides; L-type SALMFamides are derived from L-type 92 
SALMFamide precursors and F-type SALMFamides are derived from F-type SALMFamide 93 
precursors but in some cases F-type SALMFamide precursors also give rise to L-type 94 
SALMFamides. Furthermore, there are SALMFamides that are not strictly L-type but are L-type-95 
like and there are SALMFamides that are not strictly F-type but are F-type-like [26]. This is the 96 
SALMFamide salmagundi; a lexiconic marriage just waiting to be happen! 97 
 98 
2. Asteroidea 99 
2.1 FMRFamide-like immunoreactivity in the nervous system of the starfish Asterias rubens  100 
 In order that patterns of neuropeptide expression in starfish and other echinoderms can be 101 
described, it is necessary to first briefly outline the architecture of the nervous systems in these 102 
animals. The organisation of the nervous system in adult starfish reflects its pentaradial body plan; 103 
there are five radial nerve cords that extend along the midline of each arm linked by a circumoral 104 
nerve ring in the central disk. The radial nerve cords control the activity of rows of tube feet that 105 
enable locomotor activity. The radial nerve cords and the circumoral nerve ring comprise two parts, 106 
the ectoneural and the hyponeural, which are separated by a basement membrane. The ectoneural 107 
division comprises sensory, inter- and motor neurons, and is continuous with an extensive 108 
basiepithelial nerve plexus underlying the body wall surface. The hyponeural division is considered 109 
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to be purely motor. In visceral organs such as the cardiac stomach and the associated digestive 110 
glands (pyloric caecae), bipolar neuronal somata are located in the mucosal epithelium and have 111 
processes that form a basiepithelial nerve plexus. Neurons are also located within the coelomic 112 
epithelium of the gut and their processes innervate an underlying muscle layer, which is separated 113 
from the basiepithelial plexus by a basement membrane [11, 12, 35, 38, 58]. 114 
 Immunocytochemical studies using antibodies to the molluscan neuropeptide FMRFamide 115 
revealed immunoreactivity in the radial nerve cords and circumoral nerve ring of the starfish 116 
Asterias rubens [27]. The immunostaining was localised in cell bodies and axonal fibres in both the 117 
ectoneural and hyponeural parts of the nerve cords and nerve ring. Furthermore, immunoreactive 118 
fibres were also evident in the basiepithelial nerve plexus of the tube feet, indicating a potential role 119 
for the immunoreactive peptides in control of tube foot activity. These findings were of interest 120 
because they provided the first insight into the neuroanatomical organisation of peptidergic 121 
signalling systems in the nervous system of an echinoderm. Furthermore, although by the time this 122 
study was published FMRFamide-like immunoreactive peptides had been identified in vertebrates 123 
and a variety of protostomian invertebrates, FMRFamide-like peptides had not been identified in 124 
any deuterostomian invertebrate species. A pattern was beginning to emerge, with peptides sharing 125 
the motif FxRFamide (where x is variable) with FMRFamide only being found in protostomian 126 
invertebrates. Accordingly, it was proposed that there is a family of orthologous FMRFamide-127 
related peptides (FaRPs) in protostomians, with other FMRFamide-like peptides that have a C-128 
terminal RFamide motif being more widely distributed phylogenetically (e.g. in cnidarians and 129 
vertebrates) [60]. It was against this backdrop that it was of particular interest from an evolutionary 130 
perspective to determine the molecular identity of the peptides responsible for the FMRFamide-like 131 
immunoreactivity detected in the starfish A. rubens.    132 
 133 
2.2 Discovery of the starfish SALMFamide neuropeptides S1 and S2 134 
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 The detection of FMRFamide-like immunoreactivity (ir) in the nervous system of A. rubens, 135 
as discussed above, provided a basis for efforts to purify and identify the peptide(s) responsible for 136 
this immunoreactivity. Initially a radioimmunoassay (RIA) employing antibodies to FMRFamide 137 
was used to screen extracts of nerves from A. rubens and A. forbesi that had been fractionated using 138 
high-performance liquid chromatography (HPLC). However, subsequently it was found that an 139 
antiserum (Q2) to a leucine-containing FMRFamide-like peptide (pQDPFLRFamide) detected more 140 
immunoreactivity in starfish nerve extracts and therefore Q2 was used to monitor purification of 141 
immunoreactive peaks [30]. Four peaks (B-E) were purified to homogeneity and sequenced. Peak E 142 
was identified as the amidated octapeptide GFNSALMFamide, peak C was identified as the 143 
oxidised form of the peak E peptide and peak B was identified as a C-terminal fragment 144 
(SALMFamide) of the peak E peptide. Peak D was identified as the amidated dodecapeptide 145 
SGPYSFNSGLTFamide, which shares sequence similarity (underlined) with the peak E peptide 146 
(GFNSALMFamide). Interestingly, the presence of the LxFamide motif in both peptides provided 147 
an explanation for why antibodies to pQDPFLRFamide detected more immunoreactivity in starfish 148 
nerve extracts than antibodies to FMRFamide. However, the two starfish peptides differ from 149 
FMRFamide-like peptides identified in invertebrates and vertebrates because they do not have an 150 
arginine residue in the penultimate position from the C-terminal amide. Thus, the starfish peptides 151 
are not strictly “RFamide-type” neuropeptides and therefore they were designated as founding 152 
members of a new family of neuropeptides - the SALMFamides. The octapeptide 153 
GFNSALMFamide was designated as SALMFamide-1 (or S1) and the dodecapeptide 154 
SGPYSFNSGLTFamide was designated as SALMFamide-2 (or S2) [30, 31]. S1 and S2 were the 155 
first neuropeptides to be identified in a species belonging to the phylum Echinodermata and 156 
therefore it was of interest to investigate the physiological roles of these neuropeptides in starfish. 157 
To facilitate investigation of the physiological roles of S1 and S2, antibodies to these two peptides 158 
were generated and characterised using RIA methods [29].  159 
 160 
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2.3 Localisation of SALMFamide neuropeptides in starfish larvae 161 
 The development of antibodies to S1 and S2 enabled the first investigations of the 162 
expression of native neuropeptides in echinoderm nervous systems. In the life of an echinoderm 163 
there are two nervous systems – first the larval nervous system and then the post-metamorphic 164 
nervous system of juvenile and adult animals. Accordingly, taking a chronological approach, the 165 
larval nervous system will be discussed in this section and then the adult nervous system will be 166 
discussed in section 2.4 below. 167 
 The first developmental studies of SALMFamide expression in starfish analysed S1-ir in the 168 
planktotrophic larvae of three species - Asterias rubens, Pisaster ochraceus and Patiriella regularis 169 
[7, 52]. The most comprehensive analysis of larval S1-ir has been reported for P. regularis [7] and 170 
therefore this is described below. S1-ir is first observed in early bipinnarian larvae, expressed by 171 
neurons in a bilaterally symmetrical pair of dorsolateral ganglia located anterior to the mouth. As 172 
development proceeds the number of cells in each ganglion increases and in 6-day old bipinnaria a 173 
meshwork of S1-immunoreactive neuronal processes derived from the ganglia can be seen 174 
innervating the anterior dorsal region.  These S1-immunoreactive processes also innervate the 175 
adoral and pre-oral ciliated bands, where they intermingle with fibres derived from S1-176 
immunoreactive cells in the epithelium of the ciliated bands. An S1-immunoreactive nerve tract 177 
connects the pre-oral ciliated band with a network of S1-immunoreactive fibres associated with 178 
post-oral ciliated band. By 3 weeks the network of S1-immunoreactive cells and processes becomes 179 
more prominent, particularly those associated with the pre-oral and post-oral ciliated bands, and 180 
bilaterally symmetrical S1-immunoreactive fibre tracts that project into the posterior region of the 181 
larva are evident. By the brachiolaria stage at 8 weeks a larval attachment complex has formed 182 
anteriorly and a dense meshwork of associated S1-immunoreactive fibres derived from the ganglia 183 
is apparent. Fibres from the adoral nerve plexus can be seen innervating the oesophagus and S1-184 
immunoreactive cells and processes are also present in the stomach. 185 
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 The patterns of immunoreactivity observed with S1 antibodies in the nervous system of 186 
planktotrophic starfish larvae suggest that SALMFamides may modulate ciliary activity associated 187 
with swimming and feeding. S1-immunoreactive fibres in the oesophagus and stomach may be 188 
involved in regulation of visceral muscle activity and the dense S1-immunoreactive innervation of 189 
the brachium in brachiolaria suggests a potential role in larval settlement. However, as yet, no 190 
experimental studies that investigate the effects of SALMFamides on starfish larval behaviour have 191 
been reported.  Interestingly, in species belonging to the genus Patiriella that have non-feeding 192 
(lecithotrophic) larvae (e.g. P. calcar and P. exigua), there is no bipinnaria stage and neural systems 193 
associated with feeding are not present. However, S1-immunoreactive fibres innervating the 194 
brachium are present in the brachiolaria larvae of these species. Thus, there appear to be distinct 195 
developmental programs for SALMFamidergic systems associated with control of feeding 196 
(bipinnaria) and settlement (brachiolaria) in starfish larvae [8]. 197 
 198 
2.4 The distribution of SALMFamide neuropeptides in adult starfish 199 
 Antibodies to S1 and S2 have been used to both measure (using RIA) and map (using 200 
immunocytochemistry) the distribution of these peptides in adult specimens of A. rubens [29]. RIA 201 
analysis of tissue extracts revealed, not surprisingly, that the highest concentrations of the two 202 
peptides were present in the radial nerve cords (S1; 265 pmol/g; S2 417 pmol/g). However, S1-ir 203 
and S2-ir was also detected at lower concentrations in a wide range of other organs/tissues, which 204 
included the cardiac stomach (S1; 31 pmol/g; S2 121 pmol/g), pyloric stomach (S1; 24 pmol/g; S2 205 
55 pmol/g), pyloric caecae (S1; 11 pmol/g; S2 66 pmol/g), body wall (S1; 14 pmol/g; S2 49 206 
pmol/g) and ovaries (S1; 2 pmol/g; S2 20 pmol/g). In addition S2-ir (1.4 pmol/g), but not S1-ir, was 207 
detected in the perivisceral coelomic fluid, suggesting a potential hormonal role for S2 in starfish. 208 
The widespread detection of S1-ir and S2-ir in starfish provided a basis for detailed 209 
immunocytochemical investigations of the distribution of S1- and S2-expressing cells throughout 210 
the starfish body. 211 
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 Abundant S1-ir was revealed in the radial nerve cords and circumoral nerve ring of A. 212 
rubens, localised in neuronal cell bodies and in nerve fibres in both the ectoneural and hyponeural 213 
parts of these nerve tracts [51]. The pattern of immunstaining observed was very similar to that 214 
originally reported using FMRFamide antibodies [27], with FMRFamide-immunoreactive somata 215 
and S1-immunoreactive somata located in very similar positions in the radial nerve cords. Likewise, 216 
similar to findings with FMRFamide antibodies, a dense network of S1-immunoreactive fibres was 217 
revealed in the basiepithelial nerve plexus of the tube feet. However, it is possible that some of the 218 
immunostaining detected with FMRFamide antibodies is not attributable to S1. Consistent with the 219 
RIA data, S1-immunoreactive neuronal somata were also detected in mucosal epithelia throughout 220 
the digestive system (oesophagus, cardiac stomach, pyloric stomach, pyloric caecae) with an 221 
associated network of S1-immunoreactive fibres in the basiepithelial nerve plexus. In the pyloric 222 
caecae S1-ir was also revealed in nerve fibres underlying the coelomic epithelium. In the body wall, 223 
S1-ir was revealed in the subepithelial plexus as well as in the nerve plexi underlying the coelomic 224 
epithelum, associated with circularly and longitudinally oriented muscle layers. 225 
 Analysis of the distribution of S2-ir in adult specimens of A. rubens revealed a pattern of 226 
expression broadly similar to that of S1. For example, in the cardiac stomach S2-immunoreactive 227 
cells are present in the mucosa and a dense meshwork of immunostained fibres are present in 228 
basiepithelial nerve plexus, as illustrated in Fig. 1A. However, double-labelling studies showed that 229 
S1 and S2 appear to be expressed in different populations of neurons. Furthermore, unlike with S1, 230 
no S2-ir neuronal somata were observed in the hyponeural part of the radial nerve cords [54, 55]. 231 
 Subsequent to the original reports of SALMFamide expression in A. rubens, other starfish 232 
species have been analysed using antibodies to S1 and/or S2. For example, the distribution of S1-ir 233 
in the radial nerve cords and tube feet of adult specimens of P. regularis was found to be very 234 
similar to that seen in A. rubens [7]. Likewise, analysis of both S1-ir and S2-ir in the radial nerve 235 
cords and cardiac stomach of Marthasterias glacialis revealed patterns of expression similar to A. 236 
rubens [71]. Interestingly, S1-ir has also been observed in the innervation of the gonads in the 237 
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starfish Asterina pectinifera, consistent with RIA-based detection of S1 in extracts of gonads from 238 
A. rubens [49]. However, when specimens of A. rubens were analysed immunocytochemically, no 239 
S1-ir was observed in the gonads [51]; this may be due to seasonal variation in SALMFamide 240 
expression in gonadal tissues.  241 
 242 
2.5 Pharmacological effects of SALMFamides in adult starfish 243 
The detection of S1-ir and S2-ir in the innervation of a variety of neuromuscular organs 244 
(digestive system, tube feet, apical muscle) in A. rubens (see section 2.4 above) provided a 245 
neuroanatomical basis for investigation of the pharmacological effects of SALMFamides on 246 
myoactivity. Initial studies revealed that S2, but not S1, causes relaxation of cardiac stomach 247 
preparations in vitro; no effects of S1 and S2 on tube foot and apical muscle preparations were 248 
observed [29]. However, with optimisation of the recording conditions for these experiments, it was 249 
subsequently found that both S1 and S2 cause relaxation of cardiac stomach (see Fig. 1B,C,D), tube 250 
foot and apical muscle preparations [46, 47]. When tested at the same concentration the magnitude 251 
of the relaxing effect of S2 on the three preparations was found to be significantly larger than the 252 
relaxing effect of S1 [46, 47]. Furthermore, dose-response data obtained for cardiac stomach and 253 
tube foot preparations have revealed that S2 is an order of magnitude more potent than S1 (Fig. 1C) 254 
[28, 57].  255 
 Feeding in A. rubens and many other starfish species is accomplished by eversion of the 256 
cardiac stomach over the digestible parts of prey (e.g. mussels, for A. rubens). Discovery of the 257 
relaxing effect of S1 and S2 on cardiac stomach preparations in vitro provided a rationale for 258 
investigating if this effect of S1 and S2 causes cardiac stomach eversion in vivo. Injection of 100 µl 259 
of 1 mM S2 was found to cause cardiac stomach eversion within 5 minutes in 57% of tests, whereas 260 
injection of 100 µl of 1 mM S1 caused cardiac stomach eversion within 5 minutes in only 11% of 261 
tests [47]. Thus, the effectiveness of S1 and S2 in triggering cardiac stomach eversion in vivo 262 
correlates with the potency of these peptides in vitro. Furthermore, the discovery that 263 
 12 
SALMFamides trigger cardiac stomach eversion in A. rubens provided the first insight on 264 
neurochemical mechanisms underlying the unusual extraoral feeding behaviour of starfish. Recently, 265 
a neuropeptide that triggers cardiac stomach contraction in vitro and cardiac stomach retraction in 266 
vivo has been identified as the pentapeptide NGFFYamide [65]. Thus, counteracting neuropeptide 267 
systems appear to be involved in controlling the process of cardiac stomach eversion and retraction 268 
in starfish. 269 
 The pharmacological actions of SALMFamides have also been investigated as potential 270 
regulators of hormone release in the starfish Asterina pectinifera. Gamete release in starfish is 271 
triggered by gonad-stimulating substance (GSS), a neurohormone that is present in starfish radial 272 
nerve cords and that is related to the mammalian hormone relaxin [50]. Release of GSS from radial 273 
nerve cords can be triggered in vitro by KCl-induced depolarisation and S1 causes dose-dependent 274 
inhibition of KCl-induced GSS release [49]. Thus, S1 may act as a neurotransmitter in the radial 275 
nerve cords of starfish that inhibits release of GSS. This is interesting because it suggests a 276 
potentially important role for SALMFamides as regulators of reproductive physiology in starfish. 277 
Furthermore, the detection of S1-ir in the gonads of A. pectinifera suggests that SALMFamides may 278 
regulate reproductive processes peripherally as well as centrally. 279 
 280 
2.6 Investigation of a structural basis for the differing potency of S1 and S2 in starfish 281 
Recently, a structural basis for the difference in the potency of S1 and S2 as muscle 282 
relaxants in the starfish A. rubens has been investigated [57]. The most striking difference between 283 
S1 and S2 is that S1 is an octapeptide (GFNSALMFamide) whereas S2 is a dodecapeptide 284 
(SGPYSFNSGLTFamide), with four additional N-terminal residues (SGPY). It was hypothesised, 285 
therefore, that the presence of these four residues may account for S2’s greater potency compared to 286 
S1. Synthesis of an N-terminally truncated analog of S2 (short S2 or SS2; SFNSGLTFamide) 287 
enabled experimental testing of this hypothesis. However, the results obtained were complex. SS2 288 
caused dose-dependent relaxation of cardiac stomach preparations and comparison of the relaxing 289 
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actions of S1, SS2 and S2 when tested at 1 PM revealed that SS2 was significantly more effective 290 
than S1 but only slightly less effective than S2. These findings indicated that the biological activity 291 
of S2 is largely attributable to its C-terminal octapeptide sequence (SFNSGLTFamide). When SS2 292 
was tested on tube foot preparations SS2 caused dose-dependent relaxation, but surprisingly the 293 
effects of SS2 at 10 PM were consistently larger than the effects of S2 at the same concentration. 294 
Conversely, when the effects of S1, S2 and SS2 were compared at 1 PM, SS2 was significantly 295 
more effective than S1 but significantly less effective than S2. Thus, results from tests at 10 PM 296 
indicate that the presence of the N-terminal SGPY sequence impairs the bioactivity of S2, while 297 
results from tests at 1 PM indicate that the presence of the N-terminal SGPY sequence contributes 298 
to the bioactivity of S2. Further studies are required to gain understanding of these complex 299 
structure-activity relationships, which would be facilitated by identification of the receptors that 300 
mediate the effects of SALMFamides in starfish.  301 
In parallel with in vitro pharmacological studies that compared the bioactivity of S1, S2 and 302 
SS2, spectroscopic methods have been employed to compare the solution conformations of these 303 
peptides [57]. Use of circular dichroism spectroscopy showed that S1 does not have a defined 304 
structure in aqueous solution and this was supported by 2D nuclear magnetic resonance 305 
experiments; these findings are consistent with previous studies on other small neuropeptides.  In 306 
contrast, S2 was found to have a well-defined conformation in aqueous solution. However, this was 307 
concentration dependent, with increasing concentration inducing a transition from an unstructured 308 
to a structured conformation. This property of S2 was not, however, observed with the N-terminally 309 
truncated analog of S2, SS2 (SFNSGLTFamide). Collectively, the data obtained indicate that the N-310 
terminal region of S2 facilitates self-association of this neuropeptide at high concentrations. The 311 
functional significance of this property of S2 is not known, but it may have relevance to the 312 
biosynthesis and/or bioactivity of S2 in vivo. Further investigation of the structure-activity 313 
relationships of starfish SALMFamides is now needed following the recent discovery that S1 and 314 
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S2 are derived from precursor proteins that contain many other members of this neuropeptide 315 
family, as discussed below in section 2.7.     316 
 317 
2.7 More than S1 and S2: SALMFamide precursor proteins reveal the diversity of SALMFamides in 318 
starfish 319 
 When the prototype SALMFamides S1 and S2 were originally isolated from extracts of A. 320 
rubens and A. forbesi using antibodies the FMRFamide-like peptide pQDPFLRFamide, some 321 
additional minor peaks of immunoreactivity were detected but these were not identified. With the 322 
development of antibodies to S1 and S2 it became possible to screen starfish nerve extracts for 323 
putative additional S1-like and/or S2-like neuropeptides. However, when HPLC-fractionated nerve 324 
extracts from A. rubens were assayed using S1-antibodies only a single peak of immunoreactivity 325 
was detected and this was identified as S1 [31]. 326 
 The development of antibodies to S1 and S2 also enabled purification and identification of 327 
SALMFamides from other starfish species. Thus, analysis of nerve extracts from the starfish 328 
Pycnopodia helianthoides revealed that S1 is also present in this species [31], indicating that this 329 
peptide may be conserved amongst starfish species. However, as with the analysis of nerve extracts 330 
from A. rubens, no additional peaks of S1-like-ir were detected in P. helianthoides. Interestingly, 331 
however, when HPLC-fractionated nerve extracts from the starfish species Marthasterias glacialis 332 
were assayed several peaks of S1-like-ir and/or S2-like-ir were detected [72]. Five of these were 333 
successfully purified to homogeneity and sequenced. One of the peaks (peak B3) was identified as 334 
S1, providing further evidence that the S1 peptide may be conserved amongst starfish species. An 335 
S2-like immunoreactive peak (A2) was identified as SGPYSMTSGLTFamide, a dodecapeptide that 336 
is similar to the Asterias S2 peptide. Thus, this revealed for the first time the occurrence of S2-like 337 
peptides in other starfish species but, unlike the conserved S1 peptide, the sequences of S2-type 338 
peptides were found to vary between starfish genera. Furthermore, two S1-like immunoreactive 339 
peaks (A1 and B1) detected in nerve extracts from M. glacialis were identified as the amidated 340 
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octapeptide AYQTGLPFamide and the S1-like immunoreactive peak B2 was identified as 341 
AYHSALPFamide. Thus, it became apparent for the first time that the molecular diversity of 342 
SALMFamide neuropeptides in starfish is more complex than just a pair of peptides (S1 and S2). 343 
 Sequencing of the genome of the starfish Patiria miniata has recently provided the first 344 
insights into the structure of starfish SALMFamide precursor proteins and the diversity of 345 
SALMFamide neuropeptides that occur in starfish species [26]. Genes encoding two SALMFamide 346 
precursor proteins were identified. One precursor comprises S1 and six other putative neuropeptides, 347 
five of which are like S1 in having the C-terminal motif SxLxFamide or TxLxFamide. The other 348 
precursor comprises a putative S2-like peptide (SNGPYSMSGLRSLTFamide) and eight other 349 
putative peptides, six of which that have the C-terminal motif SxFxFamide (Fig. 2, 3). Discovery of 350 
these precursor sequences provided several important insights on SALMFamides in starfish. Firstly, 351 
S1 and the S2-like peptide are derived from different precursor proteins, a finding that is consistent 352 
with earlier observations from immunocytochemical studies, which revealed that S1-ir and S2-ir are 353 
localised in different populations of neurons in the nervous system of A. rubens [54, 55]. Secondly, 354 
the occurrence of two types of SALMFamides is evident – L-type SALMFamides, which typically 355 
have the C-terminal motif SxLxFamide, and F-type SALMFamides, which typically have the C-356 
terminal motif SxFxFamide. Thirdly, one of the precursor proteins is an L-type SALMFamide 357 
precursor, giving rise to S1 and other L-type peptides, some of which are structurally similar to L-358 
type SALMFamides that were identified previously in nerve extracts from M. glacialis. Fourthly, 359 
the second precursor protein is largely comprised of F-type SALMFamides and therefore it is 360 
predominantly an F-type SALMFamide precursor; however, this protein is also the precursor of an 361 
S2-like peptide, which is an L-type SALMFamide. Fifthly, some of the putative peptides deviate 362 
from the canonical L-type SALMFamide motif, SxLxFamide, or the F-type SALMFamide motif, 363 
SxFxFamide. For example, in two of the putative peptides derived from the S1 precursor the serine 364 
residue is replaced by a structurally similar amino acid, threonine. Furthermore, in one of the 365 
peptides derived from the S1 precursor, the C-terminal phenylalanine is replaced by the structurally 366 
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similar amino acid tyrosine. Furthermore, there are “F-type-like” peptides derived from the F-type 367 
SALMFamide precursor that deviate from the canonical F-type SALMFamide motif (SxFxFamide) 368 
and these include two peptides with the C-terminal pentapeptide sequences PFYPYamide and 369 
RSYAFamide.  370 
 Taking a broader perspective, what is perhaps most striking from these data is the large 371 
number of putative SALMFamide neuropeptides that appear to be present in P. miniata; in total 372 
there are 16 putative SALMFamides neuropeptides [26]. But is this representative of other starfish? 373 
It would appear that it is – we have recently determined the sequences of the SALMFamide 374 
precursors from A. rubens and have found that S1 is derived from a precursor protein that contains 375 
six other L-type or L-type-like SALMFamides and S2 is derived from a precursor protein that 376 
contains seven F-type or F-type-like SALMFamides (D. Semmens, M. Pancholi, M. Elphick, 377 
unpublished data). Thus, in A. rubens, in addition to the prototypes S1 and S2, there are thirteen 378 
other putative SALMFamide neuropeptides. As will be discussed in more detail below in section 7, 379 
this SALMFamide salmagundi invites functional explanations and future work will need to address 380 
this issue in starfish. For example, nothing is known about the actions of F-type SALMFamides in 381 
starfish; do they act as muscle relaxants like their L-type counterparts? We do, however, have some 382 
insights into the actions of L-type SALMFamides in starfish, additional to the well-characterised 383 
actions of S1 and S2. When the L-type SALMFamide AYHSALPFamide (also known as MagS3) 384 
was identified in M. glacialis its effects on cardiac stomach preparations from A. rubens were 385 
examined. Like S1 and S2, MagS3 caused dose-dependent relaxation of cardiac stomach 386 
preparations but with lower efficacy than S1 or S2 when tested at 1 µM [72]. Further studies are 387 
now needed in which the effects of all of the SALMFamides present in a starfish species are 388 
examined and compared both individually and as mixtures that reflect the natural composition of 389 
neuropeptide “cocktails” that are derived from a common precursor protein.  390 
 391 
3. Holothuroidea 392 
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3.1 FMRFamide-like immunoreactivity in sea cucumbers 393 
 The presence of FMRFamide-like ir in sea cucumbers was first reported in an 394 
immunocytochemical study of Holothuria glaberrima [34]. Immunostained neuronal somata and 395 
fibres were observed in the radial nerve cords, oesophagus and both the large and small intestine. 396 
Interestingly, many of the FMRFamide-like immunoreactive fibres in the digestive tract were also 397 
immunoreactive with antibodies to cholecystokinin (CCK), which shares C-terminal sequence 398 
similarity (MDFamide) with FMRFamide. Therefore, this may have reflected cross-reactivity of the 399 
immunoreactive peptides with both FMRFamide antibodies and CCK antibodies. 400 
 More recently, FMRFamide antibodies have been used for an immunocytochemical analysis 401 
of the sea cucumber Holothuria scabra [1]. As in H. glaberrima, immunoreactivity was observed in 402 
the radial nerve cords and in nerve plexi of the submucosal and serosal layers of the digestive tract. 403 
However, FMRFamide-like-ir was also detected in other organs including the testes, the respiratory 404 
trees and the stone canal. Furthermore, efforts were made to characterize the immunoreactive 405 
peptides using HPLC and dot-blotting methods but the molecular identity of the FMRFamide-like 406 
immunoreactive peptides in Holothuria scabra was not determined. 407 
  Another recent study used FMRFamide antibodies for analysis of the nervous system of the 408 
sea cucumber species Leptosynapta clarki, which is semi-transparent and therefore amenable for 409 
whole-mount immunstaining and imaging using confocal microscopy [41]. Immunoreactive cell 410 
bodies were observed in the buccal tentacles, oesophageal region and closely associated with the 411 
radial nerve cords. Sensory-like cells in the tentacles project toward the circumoral nerve ring, 412 
while cells close to the radial nerve cords have processes that are in close association with muscle 413 
and other body wall structures. 414 
 The molecular identity of the neuropeptides that are responsible for the FMRFamide-like-ir 415 
that is observed in sea cucumbers is not known, but it is likely that it is at least partially attributable 416 
to SALMFamide-type neuropeptides (see section 3.2 below). However, the possibility remains that 417 
other types of neuropeptide are also revealed by FMRFamide antibodies in sea cucumbers (and 418 
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other echinoderms). For example, a transcript encoding a putative neuropeptide 419 
(PYKFMRWamide) that shares C-terminal sequence similarity with FMRFamide was recently 420 
identified in the sea cucumber Apostichopus japonicus [63]. This peptide belongs to the luqin 421 
neuropeptide family, the prototype for which was originally identified in molluscs [2]. Further 422 
studies are now needed to investigate if this luqin-type neuropeptide contributes to the patterns of 423 
FMRFamide-like-ir observed in sea cucumbers. 424 
 425 
3.2 Discovery of SALMFamide neuropeptides in sea cucumbers. 426 
 The identification of the starfish SALMFamides S1 and S2 was enabled by use of antibodies 427 
to the FMRFamide-like peptide pQDPFLRFamide to monitor peptide purification [30]. So the same 428 
strategy was employed to identify FMRFamide-like peptides in the sea cucumber H. glaberrima. 429 
Two peptides were purified to homogeneity and identified as the amidated heptapeptide 430 
GFSKYLFamide and the amidated octapeptide SGYSVLYFamide [20]. Discovery of these 431 
peptides revealed for the first time that SALMFamide-type neuropeptides do not only occur in 432 
starfish but are also present in other echinoderms. Furthermore, comparison of the sequences of S1, 433 
S2 and the two peptides identified in H. glaberrima revealed a conserved C-terminal motif – 434 
SxLxFamide (where x is variable). Thus, the concept of a family of SALMFamide neuropeptides in 435 
echinoderms emerged [28]. 436 
 Completely independent of the discovery of GFSKYLFamide and SGYSVLYFamide in H. 437 
glaberrima, two SALMFamides were identified in another holothurian species, the edible sea 438 
cucumber A. japonicus [56]. Here peptide purification was accompanied by use of bioassays for 439 
myoactivity and two peptides that cause muscle relaxation were identified as GYSPFMFamide and 440 
FKSPFMFamide. Analysis of the sequences of these two peptides revealed similarities with the two 441 
peptides identified in H. glaberrima, and therefore they were categorised as members of the 442 
SALMFamide neuropeptide family. Importantly, however, the two A. japonicus peptides have a 443 
SxFxFamide motif, which contrasts with the SxLxFamide motif of S1, S2 and the two 444 
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SALMFamides identified in H. glaberrima. Thus, the discovery of the SALMFamides from A. 445 
japonicus provided the first insight on the existence of two types of SALMFamides in echinoderms: 446 
L-type SALMFamides that have the C-terminal SxLxFamide motif and F-type SALMFamides that 447 
have the C-terminal SxFxFamide motif [28].   448 
 449 
3.3 SALMFamide expression in sea cucumber larvae 450 
 To date, there are no published reports of studies employing immunocytochemical methods 451 
to analyse SALMFamide expression in sea cucumber larvae. However, an excellent framework for 452 
anatomical analysis of SALMFamide expression in sea cucumber larvae has been provided by 453 
detailed description of neural development in A. japonicus [53]. Furthermore, there are 454 
transcriptome data available that indicate that SALMFamides are expressed in sea cucumber larvae. 455 
Transcriptome sequence data have been obtained for the gastrula and larval stages of Parastichopus 456 
parvimensis. These sequence data are available for BLAST analysis at http://www.spbase.org/Pp/ 457 
and analysis of these data reveals transcripts for two SALMFamide-type precursor proteins in 458 
larvae, but not in gastrulae. Only a partial sequence is available for one of the transcripts 459 
(Locus_16236) but analysis of this sequence reveals that it contains the putative F-type 460 
SALMFamide ARYSPFMFamide, which is very similar to one of the putative F-type 461 
SALMFamides that has recently been identified in A. japonicus (ARYSPFTFamide; see section 3.6 462 
below). The second transcript (Locus_15676) encodes a precursor protein comprising three L-type 463 
or L-type-like SALMFamides, which shares 95% sequence identity with the L-type SALMFamide 464 
precursor that has recently been identified in A. japonicus (see section 3.6 below). These data 465 
indicate that both L-type and F-type SALMFamides are expressed in sea cucumber larvae. 466 
Furthermore, these data provide a basis for investigation of SALMFamide expression in sea 467 
cucumber larvae using mRNA in situ hybridization methods and/or immunocytochemistry. It will 468 
be interesting to compare patterns of SALMFamide expression observed in sea cucumber larvae 469 
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with reported patterns of SALMFamide expression in starfish and sea urchin larvae (see sections 470 
2.3 and 4.2).     471 
 472 
3.4. Localisation of the SALMFamide neuropeptide GFSKLYFamide in the sea cucumber H. 473 
glaberrima 474 
 With the discovery of the L-type SALMFamides GFSKYLFamide and SGYSVLYFamide 475 
in H. glaberrima it was possible to investigate the anatomical distribution of SALMFamide-type 476 
neuropeptides in a sea cucumber species for the first time. Antibodies to the peptide 477 
GFSKYLFamide were generated and used for immunocytochemical studies [18]. 478 
 GFSKYLFamide-ir was detected in neuronal somata and fibres in both the ectoneural and 479 
hyponeural parts of the radial nerve cords and immunoreactive fibres were evident in the 480 
longitudinal and circular muscle layers of the body wall. GFSKYLFamide-ir somata and fibres 481 
were also revealed in appendages associated with the body wall of sea cucumbers - the buccal 482 
tentacles, which serve as feeding organs, and the locomotory tube feet [18].  483 
 Turning to visceral organs, GFSKYLFamide-ir was revealed throughout the digestive 484 
system, including the oesophagus, small intestine and large intestine, with prominent 485 
immunoreactivity localised in somata and fibres in the serosal layer. Immunoreactive cell bodies 486 
were also evident in the mucosal layer of the oesophagus and intestine, and in the oesophagus these 487 
gave rise to a network of GFSKYLFamide-immunoreactive fibres in the submucosal nerve plexus. 488 
Furthermore, analysis of intestinal tissue at the electron microscopic level revealed that the 489 
GFSKYLFamide-ir was localised in dense cord vesicles in both somata and fibres, consistent with 490 
the notion that this peptide is a secreted neuropeptide in sea cucumbers.  Organs that are closely 491 
associated with the digestive system in holothurians are the respiratory trees, which are 492 
evaginations of the cloaca; as in the digestive system, a prominent GFSKYLFamide-493 
immunoreactive plexus was observed in the serosal layer of the respiratory trees. Finally, 494 
GFSKYLFamide-ir was revealed in the tubular reproductive system of H. glaberrima, with 495 
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immunostaining evident in somata located in the coelomic epithelium and in sub-epithelial fibres in 496 
both male and female gonads [18]. 497 
 What is immediately apparent from this overview of the distribution of GFSKYLFamide-ir 498 
in H. glaberrima is that expression is widespread and associated with the majority of organ systems. 499 
In this respect, the findings are similar to findings from analysis of SALMFamide expression in 500 
adult starfish (as described in section 2.4 above). Furthermore, these anatomical data provided an 501 
expectation for pleiotropic actions of SALMFamides in sea cucumbers.        502 
    503 
3.5. Pharmacological effects of SALMFamide neuropeptides in sea cucumbers 504 
 Consistent with the presence of GFSKLYFamide-ir fibres in the intestine of H. glaberrima, 505 
application of synthetic GFSKLYFamide to in vitro preparations of large intestine from this species 506 
caused dose-dependent relaxation at concentrations ranging from 10-10 to 10-6 M [19]. At 10-5 M the 507 
relaxing effect of GFSKLYFamide was much smaller than at 10-6 M, indicative of desensitisation at 508 
high peptide concentrations. Relaxing effects of GFSKLYFamide were observed on longitudinal 509 
strips of intestine as well as rings of intestinal tissue, indicating that the peptide acts on both the 510 
longitudinally and circularly orientated muscle layers. Furthermore, application of GFSKLYFamide 511 
also reversed ACh-induced contraction of intestinal preparations. A dose-dependent relaxing action 512 
of GFSKLYFamide was also observed when tested on strips of longitudinal body wall muscle from 513 
H. glaberrima. Effects were observed at concentrations ranging from 10-10 to 10-6 M, but the 514 
maximal effect was reached with 10-8 M [19].  515 
 The discovery that GFSKLYFamide causes relaxation of both intestinal and body wall 516 
muscle preparations from H. glaberrima was consistent with the relaxing effects observed with S1 517 
and S2 when tested on neuromuscular preparations from the starfish A. rubens (see section 2.5 518 
above). Furthermore, collectively these findings indicate that SALMFamide neuropeptides may act 519 
as muscle relaxants throughout the Phylum Echinodermata [28]. 520 
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 Further evidence that SALMFamides have a general action as muscle relaxants was 521 
obtained with the discovery of the first F-type SALMFamides to be identified in an echinoderm: 522 
GYSPFMFamide and FKSPFMFamide [56]. Thus, these two peptides were isolated from the sea 523 
cucumber A. japonicus on account of their relaxing effect on intestine preparations from this species. 524 
Interestingly, however, these peptides do not cause relaxation of longitudinal body wall muscle 525 
preparations from A. japonicus. This contrasts with the relaxing effect of the L-type SALMFamide 526 
GFSKLYFamide on longitudinal body wall muscle preparations from H. glaberrima. These 527 
findings may indicate that L-type SALMFamides and F-type SALMFamides exert effects by 528 
binding to different receptor types. 529 
 530 
3.6 SALMFamide precursor proteins reveal SALMFamide diversity in sea cucumbers  531 
 Sequencing of the transcriptome of the sea cucumber A. japonicus has enabled identification 532 
of SALMFamide precursor proteins in this species. Thus, a transcript was identified that encodes 533 
the precursor of the two F-type SALMFamides (GYSPFMFamide and FKSPFMFamide) that were 534 
purified from this species on account of their relaxing effects on muscle preparations [24]. The 535 
precursor also contains two other putative F-type SALMFamides, ARYSPFTFamide and 536 
GHRGGQFSQFKFamide and two F-type-like SALMFamides - GVPPYVVKVTYamide and 537 
FKSSFYLamide. Furthermore, this SALMFamide precursor protein also contains two putative L-538 
type SALMFamides (GGSALYFamide and VPELAESDGGQSKLYFamide), which are homologs 539 
of the two L-type SALMFamides originally isolated from H. glaberrima (GFSKYLFamide and 540 
SGYSVLYFamide) (Fig. 2, 3). Thus, this is an F-type SALMFamide precursor but, like the F-type 541 
SALMFamide precursor in the starfish P. miniata, it also gives rise to a smaller number of L-type 542 
SALMFamides. This suggests, therefore, that the presence of L-type SALMFamides in F-type 543 
SALMFamide precursors may be an evolutionarily conserved and therefore functionally relevant 544 
phenomenon. 545 
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 In A. japonicus, as in the starfish P. miniata, there is also a second SALMFamide precursor 546 
that contains only L-type SALMFamides. Unlike the P. miniata L-type SALMFamide precursor, 547 
which contains seven putative SALMFamides, the A. japonicus L-type SALMFamide precursor 548 
contains only three L-type or L-type-like SALMFamides: TRSRSMFGNTALPFamide, 549 
VVSRAWSPLVGQTGIAFamide and MGFTGNTGILLamide (Fig. 2, 3) [26]. Nothing is known 550 
about the neuroanatomical expression of the L-type SALMFamide precursor or the pharmacological 551 
actions of its putative neuropeptide products. It will be of interest to compare the expression and 552 
actions of neuropeptides derived from the L-type SALMFamide precursor with the expression and 553 
actions of neuropeptides derived from the F-type SALMFamide precursor, which also contains L-554 
type SALMFamides. 555 
 556 
4. Echinoidea 557 
4.1 SALMFamide-like immunoreactive peptides in the sea urchin Echinus esculentus 558 
 The development of radioimmunoassays for the starfish SALMFamides S1 and S2, as 559 
described above in section 2.2 above, facilitated investigation of the occurrence of structurally 560 
related SALMFamides in other echinoderms. With SALMFamides having already been identified 561 
in a holothurian species (see section 3.2 above), effort was focused on a species belonging to the 562 
class Echinoidea, the sea urchin Echinus esculentus [32]. Because it is difficult to dissect nerves 563 
from sea urchins, acetone extracts of whole animals were analysed. This revealed four 564 
chromatographically distinct peaks of S2-like-ir, which were labelled peaks 1-4. Only one of these 565 
peaks (peak 3) was purified to homogeneity and subjected to sequencing. This revealed that peak 3 566 
has the N-terminal sequence Met-Arg-Tyr-His but it was not possible to obtain the complete 567 
sequence of this peptide. However, with the availability of SALMFamide precursor sequences from 568 
a sea urchin species (see section 4.5 below) it was possible in retrospect to deduce that the Echinus 569 
peak 3 peptide is probably a homolog of a SALMFamide neuropeptide that is a predicted product of 570 
the L-type SALMFamide precursor in Strongylocentrotus purpuratus – MRLHPGLLFamide [64]. 571 
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This peptide has the N-terminal tetrapeptide sequence MRLH, which is very similar to the partial 572 
sequence obtained for the Echinus peak 3 peptide (MRYH).  573 
  574 
4.2. Distribution of SALMFamide-type neuropeptides in larval echinoids 575 
 The first investigation of SALMFamide expression in the larval nervous system of an 576 
echinoderm employed use of antibodies to S1 for immunocytochemical analysis of the larvae of the 577 
sand dollar Dendraster excentricus [67]. S1-immunoreactive fibres first appear in the apical 578 
ganglion between 56 h and 72 h. By 6 days (4-6 arm plutei), 2-4 pairs of S1-immunoreactive cell 579 
bodies can be seen, and by 21 days (8-arm plutei) there are 9-10 pairs of S1- immunoreactive cell 580 
bodies in the apical ganglion. S1-immunoreactive cell bodies are also present in the oral ganglion, 581 
first evident in early 4-arm plutei as 2-4 cells and then increasing to 6 pairs by 3 weeks (8-arm 582 
plutei). From 12-13 days (6-8 arm plutei) a network of S1-immunoreactive fibres is also present in 583 
the oesophagus and by 21 days the process of single S1-immunoreactive cell can be seen encircling 584 
the pyloric sphincter of the larval gut. 585 
 SALMFamide expression has also been analysed in larvae of the sea urchin Psammechinus 586 
miliaris using antibodies to S1 [3], and the patterns of immunoreactivity are similar to those seen in 587 
sand dollar larvae (see above). A population of at least 20 pairs of S1-immunoreactive cells are 588 
evident in the apical ganglion in mature 8-armed plutei; a smaller population of S1-immunoreactive 589 
cells is associated with the lower lip. A plexus of S1-immunoreactive cells and processes develops 590 
around the pylorus at the posterior end of the stomach, which is first apparent as a single cell and 591 
fibre in 6-arm plutei. In mature larvae S1-ir can also be seen in the adult rudiment, with the 592 
SALMFamidergic nerve fibres delineating the five radial nerves that innervate the primary tube feet. 593 
A novel feature of the study [3] was the use of antibodies to S2, which revealed a SALMFamidergic 594 
system distinct from that revealed by antibodies to S1. Thus, S2-ir was observed in the cell bodies 595 
of neurons that are located between the anterolateral and posterodorsal arms and that have processes 596 
underlying the ciliated bands. 597 
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 The patterns of SALMFamide expression in echinoid larvae point to roles in neural 598 
processing of sensory signals in the apical ganglion and regulation of the ciliary activity required 599 
for swimming and feeding. The S1-ir nerve plexus associated with the stomach pylorus is 600 
suggestive of a role in regulation of gut muscle activity; possibly a relaxing action, given the now 601 
well established effects of SALMFamides as muscle relaxants in adult echinoderms [28]. 602 
Furthermore, with identification of genes encoding SALMFamides in sea urchins (see section 4.5 603 
below), there are now opportunities to experimentally investigate SALMFamide function in 604 
echinoid larvae. 605 
 606 
4.3. Distribution of SALMFamide-type neuropeptides in adult echinoids 607 
  Currently, very little is known about the anatomical distribution of SALMFamide 608 
neuropeptides in adult echinoids. However, immunocytochemical analysis of the sea urchin Arbacia 609 
lixula using antibodies to the starfish SALMFamide S2 has revealed immunoreactivity in the podial 610 
nerve that innervates the tube feet [38]. This finding is consistent with the detection of S1-ir and S2-611 
ir in the basiepithelial plexus of starfish tube feet. Furthermore, it suggests a potential role for 612 
SALMFamides in regulation of tube foot motility in sea urchins (see section 4.4 below). 613 
 614 
4.4 Pharmacological effects of SALMFamide neuropeptides in adult echinoids 615 
 The molecular identity of echinoid SALMFamide neuropeptides has only been determined 616 
relatively recently, through the analysis of genome/transcriptome sequence data (see section 4.4 617 
below). Therefore, as yet there are no published reports of the effects of native SALMFamides on 618 
echinoid preparations. However, the effects of the starfish SALMFamides S1 and S2 on tube foot 619 
preparations from the sea urchin Echinus esculentus have been examined and both peptides cause 620 
relaxation,[32], consistent with the detection of S2-like-ir in the innervation of tube feet in the sea 621 
urchin Arbacia lixula [38]. Furthermore, these findings provide further evidence that 622 
SALMFamide-type neuropeptides act as muscle relaxants throughout the phylum Echinodermata.  623 
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 624 
4.5 SALMFamide precursor proteins reveal the diversity of SALMFamides in sea urchins 625 
 The sea urchin Strongylocentrotus purpuratus was the first echinoderm species to have its 626 
genome sequenced and BLAST analysis of the sequence data enabled determination of the 627 
sequence of the first SALMFamide neuropeptide precursor to be identified - a precursor comprising 628 
seven putative F-type SALMFamides, which were named SpurS1 – SpurS7 [32]. Four of the 629 
peptides have the canonical F-type SALMFamide motif SxFxFamide (SpurS1, SpurS2, SpurS3 and 630 
SpurS6). However, the serine residue is replaced by a proline residue in two of the peptides (SpurS4 631 
and SpurS5) and by a leucine residue in one of the peptides (SpursS7) (Fig. 2, 3). 632 
 Subsequently, analysis of neural trancriptome sequence data enabled identification of an L-633 
type SALMFamide precursor in S. purpuratus [64]. This protein comprises just two putative 634 
SALMFamides, NMGSIHSHSGIHFamide (SpurS8) and MRLHPGLLFamide (SpurS9; probably a 635 
homolog of the peak 3 peptide purified from Echinus - see section 4.1 above). SpurS8 has the C-636 
terminal motif SxIxFamide, which is structurally very similar to the canonical L-type SALMFamide 637 
motif (SxLxFamide), whereas in SpurS9 the canonical serine residue is replaced by a proline (Fig. 2, 638 
3). 639 
 Since completion of the S. purpuratus genome project, genome sequence data have been 640 
obtained from other sea urchin species. Analysis of partial SALMFamide precursor sequences 641 
obtained from Strongylocentrotus franiscanus reveals peptides that are identical to SpurS1, -S2, -S3, 642 
-S4, -S7 and -S8, as might perhaps be expected for species belonging to the same genus (A. Patel 643 
and M. Elphick, unpublished observations from data available at http://www.spbase.org/SpBase/). 644 
However, analysis of genome sequence data obtained for Lytechinus variegatus, a sea urchin 645 
species that is more distantly related to S. purpuratus, reveals sequence divergence in its two 646 
putative L-type SALMFamides and seven putative F-type SALMFamides, with amino acid 647 
substitutions per peptide ranging from just one to as many as seven (A. Patel and M. Elphick, 648 
unpublished observations from data available at http://www.spbase.org/SpBase/) 649 
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 650 
5. Ophiuroidea 651 
5.1 Detection of SALMFamide-like immunoreactive peptides in ophiuroids 652 
 In parallel with studies using antibodies to S1 and/or S2 to assay for SALMFamide-type 653 
neuropeptides in the sea urchin Echinus esculentus (see section 4.1 above), extracts of the brittle 654 
star Ophiura ophiura were analysed using the same methodology. S1-like-ir was detected in a range 655 
of HPLC-separated fractions but the levels of immunoreactivity were not sufficient to enable 656 
purification and sequencing of the immunoreactive peptides [23]. S1-like-ir and S2-like-ir have also 657 
been detected in extracts of the brittle star species Amphipholis squamata [4]. To date no brittle star 658 
SALMFamide-type neuropeptides have been purified and sequenced. However, as discussed in 659 
section 5.5 below, insights on the sequences of SALMFamides in ophiuroids have been obtained 660 
from transcriptome sequence data.   661 
 662 
5.2 Localisation of SALMFamide-like immunoreactivity in brittle star larvae 663 
 Analysis of the development and organisation of the nervous system in brittle star larvae has 664 
been facilitated recently through use of antibodies to synaptotagmin. Using this approach neural 665 
development has been described in the brittle star species Amphipholis kochii and Amphiura 666 
filiformis [22, 40]. The distribution of larval SALMFamide expression has been examined in the 667 
brittle star species Ophiactis resiliens using antibodies to S1 [9]. S1-like-ir is first observed in 6-668 
armed ophioplutei, associated with a nerve containing several cell bodies that encircles the stomach. 669 
By the 8-armed stage, S1-ir is also evident in fibres innervating the pre-oral ciliated band, the post-670 
oral transverse ciliated band and the adoral ciliated band. A cluster of 2-3 S1-like-immunoreactive 671 
cell bodies is present at the base of the antero-lateral arms. In advanced ophioplutei (90 days) the 672 
S1-like-immunoreactive neural elements associated with the gut and ciliated bands begin to 673 
degenerate but a new group of S1-like-immunoreactive cells appears along the proximal end of the 674 
antero-lateral arms. In metamorphosing larvae (98-100 days) S1-like immunoreactive fibres can be 675 
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seen in the developing rudiment. As with the other echinoderm classes, at present nothing is known 676 
about the physiological roles of SALMFamides in brittle star larvae. Nevertheless, the patterns of 677 
expression are indicative of roles in regulation swimming, feeding and gut activity. Furthermore, 678 
with the molecular identification of SALMFamides in brittle stars (see section 5.5) it may soon be 679 
possible to directly address this issue by testing the pharmacological actions of synthetic peptides. 680 
 681 
5.3 Localisation of SALMFamide-like immunoreactivity in adult brittle stars 682 
 Although SALMFamide-type neuropeptides have not been purified from ophiuroids, 683 
antibodies to S1 have been used to examine the presence and distribution of SALMFamide-like 684 
peptides in adult brittle stars. A detailed immunocytochemical study of the brittle star species 685 
Ophiura ophiura revealed S1-like immunoreactive neuronal somata and fibres in the ectoneural part 686 
of the radial nerves and the circumoral nerve ring [36]. The patterns of immunostaining reflected 687 
the segmental organisation of the radial nerve cords, with distinct clusters of immunoreactive cell 688 
bodies occupying the same positions in each segment of the radial nerve. The majority of 689 
immunostained cell bodies were small (8 – 15 µm); however, in each segment of the nerve cord a 690 
single giant neuron (diameter > 25 µm) or occasionally a pair of giant neurons was labelled by S1 691 
antibodies. Furthermore, in the two segments proximal to the circumoral nerve ring, the number of 692 
immunostained cell bodies was higher than in more distal segments. In the circumoral nerve ring 693 
immunostaining was largely localised in fibres, supportive of the view that “the ring cannot be 694 
regarded as a central nervous system but only functions as a link between the five segmented nerve 695 
cords” [36]. Thus, analysis of SALMFamide-like-ir in O. ophiura provided important insights on 696 
the functional organisation ophiuroid nervous systems. Furthermore, the data obtained provide a 697 
basis for investigation of SALMFamide neuropeptide function in repeatedly identifiable 698 
echinoderm neurons; thus, it may be possible to employ electrophysiological recording methods to 699 
analyse the properties of the S1-like immunoreactive giant neurons in each segment of the radial 700 
nerves. 701 
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 Subsequently, S1-antibodies were used to examine the distribution of SALMFamide-type 702 
neuropeptides in a different brittle star species, the luminescent Amphipholis squamata. However, 703 
in this study antibodies to S2 were also used in parallel with antibodies to S1 [15]. Similar to 704 
findings in O. ophiura, S1-immunoreactive cell bodies and fibres were revealed in the ectoneural 705 
part of the radial nerve cords, with a segmentally repeating pattern of immunostaining. In addition, 706 
a distinct small population of S1-ir neurons and associated processes was revealed in the 707 
hyponeural part of the radial nerve cords. S2-ir was found to be less abundant than S1-ir and was 708 
restricted to cells and fibres in the ectoneural part of the nervous system. Interestingly, this mirrors 709 
findings in A. rubens (see section 2.4 above), where S1-ir was detected in both the ectoneural and 710 
hyponeural parts of the nervous system and S2-ir was restricted to the ectoneural. Further 711 
investigation of the functional significance of these differences in patterns of staining in A. 712 
squamata would be facilitated if the peptides responsible for S1-ir and S2-ir in this species were 713 
identified (see section 5.5 below). Nevertheless, some insights on SALMFamide function in A. 714 
squamata have been obtained by using the starfish SALMFamides S1 and S2 for pharmacological 715 
studies, as described in section 5.4 below.  716 
 717 
5.4 Pharmacological effects of SALMFamides on brittle stars 718 
 The investigation of SALMFamide expression in the brittle star A. squamata, as described 719 
above, was conducted in the context of an interest in neural control of luminescence in this species. 720 
The classical neurotransmitter acetylcholine (ACh) induces low intensity light flashes from isolated 721 
arms of A. squamata [16, 17], whereas the depolarizing agent KCl induces higher intensity 722 
monophasic light production [45]. It was postulated, therefore, that KCl may induce release of other 723 
neurotransmitters or neuromodulators that regulate luminescence alongside ACh. To investigate a 724 
potential role for SALMFamides in regulating luminescence in A. squamata, the starfish 725 
SALMFamides S1 and S2 were tested in vitro on isolated arms [4]. Experiments were performed on 726 
the two varieties of A. squamata that occur naturally – black and brown (also referred to as “clear”). 727 
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Application of S1 or S2 did not induce luminescence of isolated arms from either variety. However, 728 
pretreatment with S1 significantly increased ACh-induced luminescence in both black and clear 729 
specimens, whilst pre-treatment with S2 had little or no effect on ACh-induced luminescence. 730 
These data indicate that SALMFamides may act as neuromodulators that regulate light production 731 
in A. squamata. It interesting that a potentiating effect of S1 on ACh-induced luminescence was 732 
observed because hitherto only inhibitory effects of SALMFamides have been reported (e.g. muscle 733 
relaxation; inhibition of GSS release in starfish). One possibility is that SALMFamides act to 734 
inhibit the release of inhibitory neurotransmitters such as GABA and glycine, which cause 735 
inhibition of ACh-induced luminescence in A. squamata [4]. Further investigation of the 736 
physiological roles of SALMFamides in regulation of luminescence in A. squamata would be 737 
facilitated if neuropeptides native to this species or other brittle star species are identified (see 738 
section 5.5 below).   739 
   740 
5.5 SALMFamide precursor proteins in brittle stars 741 
 Recently, a paper reporting transcriptome sequencing of the Antarctic brittle star species 742 
Ophionotus victoriae was published [6]. The sequences of 18,003 contigs were determined and 743 
analysis of these data has revealed a contig (7706) encoding a partial protein sequence that contains 744 
eleven putative F-type SALMFamides and a single putative L-type SALMFamide 745 
(RNPMNSLSALAFamide) that shares sequence similarity with the starfish SALMFamide S2 746 
(SGPYSFNSGLTFamide) (M.R. Elphick, D.C. Semmens & M.S. Clark, unpublished data). Thus, 747 
this protein appears to be a brittle star ortholog of the F-type SALMFamide precursors that have 748 
been identified in other echinoderms. On-going studies are directed toward determining the 749 
complete sequence of this protein as well as investigating the occurrence of an L-type 750 
SALMFamide precursor in Ophionotus victoriae.  751 
 752 
6. Crinoidea 753 
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 Currently, very little is known about SALMFamides in crinoids. An immunocytochemical 754 
study of pinnules from the crinoid Antedon bifida using antibodies to the starfish SALMFamide 755 
neuropeptide S2 revealed groups of S2-like immunoreactive bipolar and roundish neuronal somata 756 
(~6 µm diameter) located at the periphery of pinnular sections of the brachial nerve just before the 757 
nerve enters the ossicles [37]. These cells have processes that project along the boundary between 758 
ossicles and interossicular muscles and ligaments, whilst another process projects into the 759 
interossicular segment of the nerve. These anatomical observations suggest a possible role for 760 
SALMFamides in regulating the mechanics of interossicular muscles and ligaments in crinoids. 761 
However, there are, as yet, no reports of experimental studies investigating the pharmacological 762 
activity of SALMFamides in crinoids.  763 
 Progress in analysis of SALMFamide function in crinoids would be facilitated by 764 
identification of genes/cDNAs encoding SALMFamide precursor proteins. Currently, however, 765 
there are no genome/transcriptome sequence data available for crinoid species. Discovery of 766 
SALMFamide precursors in crinoids would be of great interest, but not only as a basis for 767 
experimental studies. Because crinoids occupy a phylogenetic position that is basal to the four other 768 
extant echinoderm classes [59], analysis of sequence data from crinoids may provide important 769 
insights into the evolution of SALMFamide neuropeptides. For example, do crinoids have both an 770 
L-type and an F-type SALMFamide precursor? If they do, then does the F-type SALMFamide 771 
precursor also contain one or more L-type SALMFamides, as has been found in starfish, sea 772 
cucumbers and brittle stars?  773 
 774 
7. Conclusions and directions for future research 775 
 Looking back over a research programme that was initiated twenty-five years ago, it is 776 
timely to assess the broader impact of the discovery of SALMFamide neuropeptides. Perhaps the 777 
greatest impact has been providing new tools (in the form of antibodies) for visualisation of 778 
echinoderm nervous systems. In particular, antibodies to the starfish SALMFamide neuropeptide S1 779 
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have been widely used to reveal for the first time the architecture of neuropeptidergic systems in a 780 
variety of echinoderms, both as larvae and as adults. These neuroanatomical studies have yielded 781 
data that have provided new insights into the organisation of echinoderm nervous systems. 782 
However, the more challenging task of determining the physiological roles of SALMFamide 783 
neuropeptides in echinoderms has not kept pace with neuroanatomical studies. Although patterns of 784 
SALMFamide expression have been revealed in larvae from several echinoderm classes, at present 785 
nothing is known about the physiological roles of SALMFamides, or indeed any neuropeptides, in 786 
echinoderm larvae. This represents an exciting field of investigation for the future, especially now 787 
that SALMFamide precursor transcript sequences have been identified in several echinoderm 788 
species. Recently, progress has been made determining the physiological roles of neuropeptides in 789 
the larval nervous systems of other marine invertebrates such as the annelid Platynereis dumerilii. 790 
For example, neuropeptides alter ciliary beat frequency, which affects the vertical distribution of 791 
larvae in the water column [13, 14]. Accordingly, similar experimental approaches to those used 792 
with Platynereis larvae could be employed to investigate neuropeptide function in echinoderm 793 
larvae. 794 
 Progress has been made, as discussed above, in revealing the pharmacological actions of 795 
SALMFamide neuropeptides in adult echinoderms and a consistent finding is relaxing effects on 796 
muscle systems [28]. Furthermore, the in vitro and in vivo relaxing effect of SALMFamides on the 797 
cardiac stomach of starfish suggests a physiological role in mediating neural control of stomach 798 
eversion associated with their extraoral feeding behaviour [47]. However, the discovery of 799 
physiological roles is determined by choices of bioassays, and it would be simplistic to conclude 800 
that the function of SALMFamides is solely to act as muscle relaxants in echinoderms. The 801 
inhibitory effect of S1 on neural release of GSS in starfish [49] points to a more general role for 802 
SALMFamides as inhibitory neurotransmitters and as such it is likely that SALMFamides have 803 
pleiotropic actions in echinoderms. 804 
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 Perhaps the most important recent breakthrough in SALMFamide research has been the 805 
identification of genes/transcripts encoding the precursors of SALMFamide neuropeptides [26]. 806 
This has revealed that a much greater diversity of SALMFamides exists in echinoderm species than 807 
had been revealed previously. This feature of SALMFamides was discussed in detail in the class-808 
specific sections of text above and is illustrated in figures 2 and 3. Thus, the currently available data 809 
indicate that in echinoderms there are two types of SALMFamide precursors: an L-type 810 
SALMFamide precursor and an F-type SALMFamide precursor.  811 
 L-type SALMFamide precursors comprise only L-type or L-type-like SALMFamides but 812 
the number of putative L-type peptides derived from L-type SALMFamide precursors ranges from 813 
just two (S. purpuratus; Echinoidea) to seven (P. miniata; Asteroidea) (Fig. 2, 3). Furthermore, 814 
comparative alignment of L-type SALMFamide precursors suggests that a common ancestral 815 
precursor protein may have comprised three L-type SALMFamides (as in A. japonicus; 816 
Holothuroidea) [26] 817 
 F-type SALMFamide precursors comprise variable numbers of F-type or F-type-like 818 
SALMFamides and typically (Asteroidea, Holothuroidea, Ophiuroidea) one or more L-type 819 
SALMFamides. In fact the first F-type SALMFamide precursor to be identified in the sea urchin S. 820 
purpuratus is atypical in comprising only F-type SALMFamides (Fig. 2, 3). Therefore, with 821 
reference to echinoderm phylogeny [59], a parsimonious explanation based on the sequence data 822 
available would be that the occurrence of one or more L-type SALMFamides in the F-type 823 
SALMFamide precursors is an ancient characteristic that dates back to the common ancestor of 824 
echinoids, holothurians, asteroids and ophiuroids. Accordingly, it would be concluded that there has 825 
been loss of L-type peptides in F-type SALMFamide precursors in the echinoid lineage.   826 
 The occurrence of multiple SALMFamide isoforms in echinoderms raises questions 827 
concerning their functional significance. Neuropeptide “cocktails” derived from common precursor 828 
proteins are, of course, not unique to SALMFamides. Indeed, it is a widespread phenomenon in the 829 
animal kingdom, particularly in invertebrates [70]. However, in spite of this, its physiological 830 
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relevance remains poorly understood. Some studies indicate that neuropeptide isoforms derived 831 
from a common precursor are functionally redundant [39], whilst other studies have revealed 832 
differential effects [33, 44]. The discovery that heterogeneous mixtures of SALMFamides are 833 
derived from common precursor proteins has provided opportunities to use this neuropeptide family 834 
as a model system to investigate the physiological significance of neuropeptide “cocktails”.  835 
 Ultimately, an understanding of the physiological relevance of the SALMFamide 836 
salmagundi will require identification and characterisation of receptors that mediate the effects of 837 
these neuropeptides. Relevant to this issue, it was recently postulated that L-type SALMFamides 838 
may belong to a bilaterian family of neuropeptides that include gonadotropin-inhibitory hormone 839 
(GnIH) in vertebrates and SIFamide-type neuropeptides in protostomian invertebrates [25]. The 840 
rationale for this hypothesis is that some SIFamide-type neuropeptides have a C-terminal 841 
SxLxFamide motif, as found in L-type SALMFamides. Further evidence can be found in the 842 
physiological roles of GnIH-type and SIFamide-type neuropeptides, which inhibit reproductive 843 
processes in vertebrates and Drosophila, respectively [68, 69]. In this respect there are similarities 844 
with the L-type SALMFamide S1, which causes inhibition of neural release of the relaxin-like 845 
gonad stmulating substance in starfish [49]. Furthermore, GnIH also stimulates feeding behaviour 846 
and it has been proposed that GnIH functions as a “molecular switch” between reproduction and 847 
feeding in vertebrates [10] It is intriguing, therefore, that SALMFamides trigger cardiac stomach 848 
eversion in starfish, indicative of a physiological role in neural control of feeding behaviour [47]. 849 
Thus, it is tempting to speculate that GnIH/SALMFamide/SIFamide-type neuropeptides may be an 850 
evolutionarily ancient family of neuropeptides that stimulate feeding and inhibit reproduction in 851 
bilaterian animals. Support for this hypothesis would be obtained if it is found that SALMFamide 852 
receptors are orthologs of the GnIH/SIFamide-type receptors that have been identified in 853 
vertebrates and in Drosophila [42, 43, 48].  854 
 It is also noteworthy that the C-terminal FxFamide motif of F-type SALMFamides is a 855 
feature of vertebrate QRFP (26RFa)-type neuropeptides, which regulate food intake in mammals by 856 
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stimulating intake of a high fat diet [62]. Accordingly, F-type SALMFamides may exert their 857 
effects by binding to echinoderm QRFP-type receptors. Testing this hypothesis is now feasible with 858 
the availability of echinoderm transcriptome/genome sequence data [5, 21, 66].  859 
 This review has looked back over a period of twenty-five years of research on 860 
SALMFamide neuropeptides, which began with a paper published in 1989 reporting FMRFamide-861 
like immunoreactivity in the starfish A. rubens. Looking ahead, key objectives for the future are to: 862 
i). determine the evolutionary relationships of echinoderm SALMFamides with neuropeptides in 863 
other phyla, which could be achieved by identifying the receptors that mediate effects of 864 
SALMFamides ii). examine more widely the physiological roles of SALMFamides in larval and 865 
adult echinoderms and iii). investigate the evolutionary and  functional significance of the 866 
“cocktails” of neuropeptides that are … the SALMFamide salmagundi.  867 
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